Works matching DE "FIBROBLAST growth factors"

Results: 5000
    1
    2
    3

    Outcome-associated factors in a molecularly defined cohort of central neurocytoma.

    Published in:
    Acta Neuropathologica, 2025, v. 149, n. 1, p. 1, doi. 10.1007/s00401-025-02894-3
    By:
    • Krech, Maja;
    • Muench, Amos;
    • Teichmann, Daniel;
    • Kuzman, Peter;
    • Suwala, Abigail K.;
    • Ippen, Franziska M.;
    • Müther, Michael;
    • Weber, Katharina J.;
    • Wenger-Alakmeh, Katharina;
    • Onken, Julia;
    • Vajkoczy, Peter;
    • Behling, Felix;
    • May, Sven-Axel;
    • Ntoulias, Georgios;
    • Krauss, Joachim K.;
    • Atallah, Oday;
    • Esmaeilzadeh, Majid;
    • Mueller, Wolf C.;
    • Heppner, Frank L.;
    • Radbruch, Helena
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Grb-ing receptor activation by the tail.

    Published in:
    Nature Structural & Molecular Biology, 2014, v. 21, n. 2, p. 113, doi. 10.1038/nsmb.2767
    By:
    • Fearon, Abbie E;
    • Grose, Richard P
    Publication type:
    Article
    31
    32
    33
    34

    Craniosynostosis.

    Published in:
    Indian Journal of Plastic Surgery, 2013, v. 46, n. 1, p. 18, doi. 10.4103/0970-0358.113702
    By:
    • Kumar Sharma, Ramesh
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism

    Published in:
    Osteoporosis International, 2020, v. 31, n. 8, p. 1461, doi. 10.1007/s00198-020-05362-8
    By:
    • Cavalier, E.;
    • Lukas, P.;
    • Bottani, M.;
    • Aarsand, A.K.;
    • Ceriotti, F.;
    • Coşkun, A.;
    • Díaz-Garzón, J.;
    • Fernàndez-Calle, P.;
    • Guerra, E.;
    • Locatelli, M.;
    • Sandberg, S.;
    • Carobene, A.;
    • on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism;
    • Åkesson, Kristina;
    • Bhattoa, Harjit Pal;
    • Bruyère, Olivier;
    • Cooper, Cyrus;
    • Eastell, Richard;
    • Garnero, Patrick;
    • Heijboer, Annemieke
    Publication type:
    Article